![Lynette Hopkinson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Lynette Hopkinson worked as the VP & Head-Cystic Fibrosis Regulatory Strategy at Vertex Pharmaceuticals, Inc. from 2014 to 2020.
She then worked as the Senior Vice President-Regulatory at Imara, Inc. from 2020 to 2021.
Prior to her career, she completed her undergraduate degree at the University of the Witwatersrand.
Antiguos cargos conocidos de Lynette Hopkinson.
| Empresas | Cargo | Fin |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Consejero General | 01/09/2020 |
| IMARA | Consejero General | - |
Formación de Lynette Hopkinson.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
19
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes novel therapeutics for patients with sickle cell disease | Health Technology |
- Bolsa de valores
- Insiders
- Lynette Hopkinson
